Diet and asthma  by BAKER, J.C & AYRES, J.G
Topical Review
Diet and asthma
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The role of food intolerance in asthma is well recognized, and where food avoidance measures are instituted
considerable improvement in asthma symptoms and in reduction in drug therapy and hospital admissions can
result. These benefits may have a greater impact in those patients with greater symptoms. However, the promise of
such benefits should not result in an approach which ignores inhaled drug therapy, or in a dietary regime which is
inappropriate in the face of mild symptoms. Whilst sub-optimal intake of dietary nutrients is also a recently
recognized potential risk factor for asthma, available data are insucient to implicate any as casual. A number of
studies have sought to establish the role of the antioxidant vitamins, A, C and E and selenium, yet others of the
elements sodium and magnesium. Sub-optimal nutrient intake may enhance asthmatic inflammation, consequently
contributing to bronchial hyperreactivity. Prospective studies of supplementation therapy are needed to confirm
this.
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The role of food intolerance in asthma is well recognized
but poorly quantified. There are considerable diculties in
recognizing and diagnosing food intolerance and the
logistics of doing so has dissuaded many clinicians from
trying. In addition, the relatively poor understanding of the
mechanisms involved in food intolerance has meant that its
very existence is doubted by some. However, where food
intolerance is recognized, and food avoidance measures
instituted, considerable improvements in asthma symptoms
and reductions in drug therapy and hospital admissions can
result. It is important to clarify terminology and establish
working definitions in this area. Different schemes have
been suggested but the one generally accepted in the U.K.,
and which we use here, is that proposed by the Royal
College of Physicians (1).
As well as food intolerance in asthma, other dietary
factors should be considered. The potential role of certain
nutrients has recently been recognized and emerging
evidence suggests that a relationship may exist between
suboptimal intakes and lung disease (2). The influence of
dietary factors on inflammatory and antioxidant activity,Received October 1999 and accepted in revised form 26 April 2000.
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toms, has been examined (3–6) as have the antioxidants
selenium (7,8) and vitamins A (9), C (10,11) and E (12,13)
and the trace elements sodium (14–18) and magnesium
(19,20).
We examine here the work done, both in food intolerance
and nutrient intake in asthma, and make recommendations
for current clinical practice and further research.
Food intolerance
EPIDEMIOLOGY
Most studies of the prevalence of food intolerance are
questionnaire based relying on self-reported perceived
adverse responses to food. The European Community
Respiratory Health Survey (ECRHS) employed a validated
questionnaire (21), which has been used in epidemiological
studies (22,23), but there are scant data on the reproduci-
bility of different questionnaires used in other studies.
Objective measures of food intolerance give a better idea of
the true prevalence but this involves challenge of each
patient with a range of foodstuffs. The double-blind
placebo-controlled food challenge (DBPCFC) is considered
to be the ‘gold standard’ (24) procedure to confirm or refute
a diagnosis of food intolerance, but the logistics of this are
substantial and it cannot be used as an epidemiological
tool. It should also be recognized that, even in an individual
with proven food intolerance, the response to ingestion of a# 2000 HARCOURT PUBLISHERS LTD
TABLE 2. Prevalence of food intolerance in brittle asthma
FCs DBPCFCs
16daily
No. of subjects: 29 18
No. of subjects reacting to
at least 1 food:
15 (52%) 12 (66%)
No. of subjects by no. of
foods reacted to:
1 0 (0%) 1 (8%)
2 6 (40%) 2 (15%)
3 4 (27%) 2 (15%)
4 5 (33%) 2 (15%)
5 0 (0%) 3 (23%)
6 0 (0%) 0 (0%)
7 0 (0%) 2 (15%)
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problem, estimates of the prevalence of adverse reactions
to food should be regarded with caution unless they are
supported by an objective measure.
Food intolerance and mild-moderate asthma
A number of studies have been conducted in a range of
countries over the last 20 years in subjects with mild–
moderate asthma. The populations have been a mix of
general populations and selected groups and it is dicult to
determine any clear pattern from these figures. In general,
rates of self-reported food intolerance in asthma are found
to be similar to those in the general population whether
considering self-reported or objectively confirmed adverse
reactions (Table 1). The discrepancy between perception
and objective evidence of an adverse reaction to food is
clear, the lowest figures for prevalence being in studies
where food challenges have been conducted. Whilst
recognizing the substantial logistical diculties of the
DBPCFC, unless it is used as a standard test, or until a
simpler test off equivalent sensitivity and specificity is
found, it will be dicult to determine the true prevalence of
food intolerance in asthma.
Food intolerance and severe asthma
Even less information is available for patients with more
severe asthma. In a clinic population of patients with brittle
asthma (Birmingham Heartlands Hospital, U. K.), around
two thirds reported at least one food which could
exacerbate their asthma. Sixty percent of the total clinic
population have subsequently undergone food challenge
studies and, whether using a protocol of dietary exclusion
followed by open food challenges (OFCs) or of dietary
exclusion followed by DBPCFCs (34) around 50% patients
showed positive responses to one or more foods, which
supported the questionnaire findings (Table 2). An adverseTABLE 1. Prevalence of food intolerance in various populations
Country Date Sample size & populat
General
population
data
Asthma
populations
Sweden (25) 1978 — 1129
Switzerland (26) 1983–5 — —
Wales (27) 1985 — 72
France (28) 1986 — 300
France (29) 1987 — 67
China (30) 1990 10 144 —
Italy (31) 1992 — —
Australia (32) 1996 — 914
Turkey (33) 1996 1884 584response can be immediate (Fig. 1), late (Fig. 2) or a dual
response.
These proportions cannot be extrapolated to all cases of
asthma at the severe end of the spectrum but the findings
would support the hypothesis that the more severe the
bronchial hyperresponsiveness the more likely it is that a
positive response to food may be demonstrated.
DIAGNOSIS
While some take the view that detection of food intolerance
in asthmatic subjects is of limited value (35), some patients,
in whom specific foods are identified as being causally
related to their asthma, benefit substantially from excluding
them from their diet (28,36).
History
Although a positive history of an adverse reaction to a food
is helpful in deciding whether an individual patient mayion % Self-reported Confirmation by
food challenge
Patients
with food
intolerance
Food
intolerance
Asthma
— 24?0 — No
229 — 24?1 No
— 4?0 — Yes
— 2?0 — Yes
— 5?8 — Yes
— 4?9 3?8 No
1?339 — 2?6 Yes
— 45?3 — No
— 4?5 13?5 No
FIG 1. Immediate positive response to DBPBFC with soya
in a patient with brittle asthma.
FIG. 2. Late positive response to DBPCFC with wheat in a
patient with brittle asthma.
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intolerance on challenge give no such history. The main
reason for this is that the unrecognized foods are those that
are staple in the diet (e.g. wheat, milk/milk products) and
presumably act as chronic potentiators of airway inflam-
mation. Where a history is positive, the pattern of
symptoms is similar to any other exacerbation of asthma,
although there may be associated symptoms in other
systems such as headache, abdominal pain and bloating,
nasal symptoms and, occasionally, skin rash.Skin prick tests (SPTs)
Burrows (37) stated that the use of SPTs in respiratory
allergic disease should be ‘used as an indicator of a subject’s
atopic predisposition rather than as a guide to the specific
cause of his complaints’. This cautious approach was
supported by later work (24), which showed them to have
poor positive predictability (25–75%) for food induced
asthma and they are now acknowledged as not being
diagnostic for food intolerance in asthma (38).
Radioallergosorbent tests (RASTs)
These tests have also been shown to have poor positive
predictability (24) (0–57%) and are considered to help in
the diagnosis of food allergy but, again, not to be diagnostic
in themselves (38). Equally, levels of total serum IgE have
not been shown to be consistently related to the presence of
a positive food challenge.
It is thus inappropriate, on the basis of skin prick tests
and/or RASTs alone, to recommend restrictive diets (39).
Histamine Release Test (HRT)
The diagnostic value of the HRT in whole blood of patients
with food allergy has been suggested as a diagnostic test for
food allergy in asthma (40) but has yet to be tested against
DBPCFC.
Top-cast/cast elisa
The cellular antigen stimulation test (CAST) is an enzyme-
labelled immunosorbent assay (ELISA) which measures
sulphidoleukotriene generation by leukocytes on specific
allergen challenge. In one study (41), which aimed to
establish the usefulness of the test in differentiating between
allergic and non-allergic status, the test yielded a 100%
sensitivity and did not produce any false positives.
However, it was unable to distinguish between health and
disease states and its role in food allergy in relation to
asthma remains to be determined.
Methacholine responsiveness
While bronchial hyperresponsiveness to methacholine is
well recognized as a marker of asthma in both the
laboratory and occupational setting, in food challenge the
picture is less clear cut. In one study, methacholine response
before, and 24 h after, DBPCFCs in 11 subjects with
asthma and a history of food-induced asthma and positive
SPTs to the suspect food (42) revealed no difference in
response after food challenge compared to placebo food
challenge. However, in another study (43), methacholine
hyperresponsiveness measured before and 4 h after
DBPCFC in 26 food-allergic asthmatic patients, showed a
greater increase in airway responsiveness following positive
DBPCFC compared to negative DBPCFC (P=0?03),
928 J. C. BAKER AND J. G. AYRESwithout inducing acute asthma. The discrepancy between
the findings of the two studies may be due to differences in
study design, the first lacking environmental controls and
the latter being conducted with children. In adults it still
has to be shown that bronchial hyperresponsiveness is a
true marker of food intolerance.
Dietary manipulation
As no single laboratory test has yet been devised to identify
food intolerance or even provide a broad screening test,
dietary manipulation is considered to be the cornerstone of
diagnosis and treatment. The method of choice for
investigators is usually that outlined by Bock et al. (44)
which comprises three main components:
(i) A period of dietary exclusion prior to food challenge
(45). The length of time for such exclusion varies. Up to 14
days (38) may be necessary in order to stabilize a patient’s
symptoms prior to food challenge, although 5 days may be
adequate (34). ‘Few Foods’ Diets (46) (providing the
patients with a minimal number of hypoallergenic foods
to provide optimal nutrition) are usually used during the
period of dietary exclusion. Alternatively, a hypoallergenic
formula drink (Elemental 028 Extra Liquid, Scientific
Hospital Supplied Ltd., U.K.) and water can be used
instead of ‘normal’ food and drinks.
(ii) A DBPCFC methodology (47). Food challenges are
usually given as lyophilized foods in opaque, dye-free
capsules. In preparing antigens for hiding in capsules,
freeze-drying and purification have been shown to decrease
or even destroy the allergenic activity of the agent (48).
Whilst this is considered the most convenient method (49),
it does not facilitate food being given in the ‘natural form’
and problems may also arise concerning the quantity of
dried foods needed to elicit symptoms, the number of
capsules required, and time taken for dissolution of the
capsule. Less frequently, due to diculty in devising
recipes, masked foods are used for challenges (48,50). This
method does, however, enable challenge foods to be given
in portion-sized doses and in the ‘natural form’ i.e. how it
was eaten when the reaction occurred. The challenge of the
methodology is to devise a masking agent suitable for all
the foods in the challenge panel to be masked for every
subject in a study. When masked in food, the suspected
agent must be undetectable by taste, smell, colour and
texture.
(iii) A subsequent diet which is nutritionally adequate. This
should be based on the evidence of a positive food challenge
(47) and be acceptable to the patient.
TREATMENT
Dietary avoidance
There is conflicting evidence as to whether oral challenge
with food causes a direct asthmatic response, or may lead to
an alteration in bronchial hyperresponsiveness thus priming
the bronchi for subsequent provocation (51). Nevertheless,the purpose of any dietary avoidance is to have a direct
impact on symptoms and food intolerance and is primarily
treated by dietary avoidance of the offending foods (52).
The most important factor influencing the effective control
of symptoms is complete avoidance, with the underlying
proviso that the dietary regime is nutritionally adequate
(for example if milk and milk products are to be avoided
then a calcium supplement should be prescribed) and is less
troublesome to the patient than any symptoms it has
alleviated.
Drug therapy
In the 1970s inhaled sodium cromoglycate was developed as
a therapy for patients with asthma, particularly those with
an allergic component (53). Subsequently its use was
assessed in asthma and urticaria due to foods. By inhalation
it blocked the airway responses following food challenge
(54), but in an oral dosage of 800 mg day71 for 1 week, or
a single dose of 1?0 g, did not block any of the asthmatic
reactions. In a study of fish-induced asthma, sodium
cromoglycate blocked the fall in FEV1 either completely
or significantly, in 16/20 patients (55). Ketotifen has been
considered to offer help in food allergy (56) and in one
study (57) of 24 patients it was found to afford protection
against the bronchial response to food challenge in
asthmatic subjects.
Inhaled bronchodilators offer the best treatment for an
acute episode induced by food, but when the attacks are
severe and rapid, and are similar in speed of onset to an
anaphylactic reaction, self-injected adrenaline (EpiPen,
AnaPen) is effective and essential.
Vitamin therapy
Vitamin C is considered by some to have a protective role in
asthma and other allergic diseases but this is not well
defined. The current literature (58) does not support a
definite indication for the use of vitamin C in asthma and
food intolerance
RELEVANT FOODS
Adverse responses have been documented to most foods
but those found to be the most allergenic in the Western
diet are egg, milk, wheat, fish, citrus fruits, peanuts and
soya (51). The respiratory system is documented as being
affected by adverse reactions to these foods. In patients
with brittle asthma a similar pattern of food responses is
seen, suggesting that it is the allergenic moieties that are of
importance, rather than the end organ sensitivity, in
determining which foods are important in asthma.
Although alcohol is a modest bronchodilator (59), many
patients with asthma report worsening of their symptoms
when it is ingested. In one study (60), 25% of a hospital
outpatient population reported that at least one alcoholic
drink made their asthma worse, the effects being in most
patients due to congeners in the beverage although the rare
DIET AND ASTHMA 929patient will respond to ethyl alcohol alone. This is
particularly marked in Oriental subjects (61), mediated
through acetaldehyde a metabolic product of ethyl alcohol.
Foods of minor significance nutritionally, but never-
theless cited recently as the cause of severe asthmatic
responses are shellfish (62), royal jelly (63) and fenugreek
(64), and are probably IgE mediated responses.
Food additives are frequently cited as a group of
foodstuffs causing problems in asthma. Some patients with
asthma report adverse responses to monosodium glutamate
(MSG), particularly if high doses are consumed (65,66),
although the mechanism is unknown. Tartrazine sensitivity
is most frequently manifested as urticaria and asthma (63)
although the mechanism is obscure and probably not truly
allergic. There is conflicting evidence concerning sulphited
foods and asthma. It is been reported that about one in nine
people with asthma have a history of asthma worsened by
drinking ‘soft drinks’ containing sulphur dioxide (68),
although these individuals may not necessarily react after
each ingestion of sulphited food (69)
Some patients with asthma are known to be sensitized to
aspirin and aspirin-induced asthma is well recognized.
Salicylate-free diets are prescribed, by some, to improve the
asthma symptoms of these individuals. There are no
published studies demonstrating the ecacy of this treat-
ment, but anecdotal evidence suggests that it is helpful in
some patients.
PRACTICE POINTS
. Consider adverse reactions to foods when taking
patient history.
. Identification and avoidance of offending foods can
lead to significant improvement in some individuals
with asthma.
. Skin pricks tests and RASTs are not diagnostic
tools for adverse reactions to food in asthma.
. Dietary manipulation is the cornerstone of
diagnosis and treatment
. Multidisciplinary team of physician, dietitian and
nurse provides the best patient care.
RESEARCH AGENDA
. Development of a simple, laboratory diagnostic
test.
. Development of more accurate, objective markers
of response.
. Investigations into mechanisms in adverse
responses to food in asthma.
. Epidemiology of adverse reactions to food in
asthma.Nutrient intake
NUTRIENTS
Magnesium
Magnesium is a known, mild bronchodilator (70) and
increased dietary magnesium has been shown to have a
beneficial effect on lung function, airway responsiveness
and wheezing in the U.K. population (71). In the latter
study the average daily intake of magnesium in healthy
adults was established from a semi-quantitative food
frequency food questionnaire and a 100 mg day71 increase
in magnesium intake was found to be independently
associated with a 27.7 ml higher FEV1 and reduced airway
reactivity to methacholine responsiveness, after adjusting
for daily intake of calcium, vitamin C, smoking, occupation
and social class. From this it might therefore be inferred
that a low magnesium intake could be involved in the
aetiology of asthma, although this remains to be proven—
association does not imply causality. However, at the severe
end of the spectrum, there is some evidence which might
support the role of magnesium in asthma. Patients with
brittle asthma show a lower magnesium intake (72)
(233 mg day71) compared to those with non-brittle asthma
(277 mg day71) and healthy adults (276 mg day71). While
this difference did not achieve statistical significance, the
number of subjects in each group whose dietary intakes of
magnesium were less than the reference nutrient intake
(RNI), was significantly higher in brittle asthma compared
to in non-brittle asthma. Together, these findings suggest a
possible role for magnesium in asthma, which merits
further research. Indeed, an investigation into the effect of
short-term change in dietary magnesium intake in moderate
asthma (73) showed that a high magnesium intake was
associated with improvement in symptom scores but not in
objective measures of airway reactivity. At present the
evidence is lacking for recommending alterations in
magnesium intake in asthma.
Sodium
Observations of the effect of dietary sodium on asthma (13)
seem to suggest that sodium deficient diets might be linked
with reduction in non-specific bronchial reactivity,
although this finding may have arisen due to confounding
between the intakes of sodium and magnesium (67). Several
studies have investigated the relationship between sodium
intake and asthma and have demonstrated small adverse
effects of increased sodium intake on bronchial reactivity,
but not on clinical symptoms. Hence there is not, at present,
any justification for recommending an alteration in sodium
intake in asthma.
Selenium
It has been hypothesized (7) that deficiency of selenium,
acting through a lowered activity of gluthathione perox-
idase, may be implicated in the pathogenesis of asthma. A
930 J. C. BAKER AND J. G. AYREScase control study control study conducted in New Zeland
(7) demonstrated a near two and near six-fold increase in
risk of asthma in subjects with the lowest range of whole
blood selenium concentrations and glutathione peroxidase
activity respectively. A Swedish (8) double-blind, placebo-
controlled study of selenium supplementation showed
significant general clinical improvement in the selenium
supplemented group as compared with the placebo group,
but this improvement could not be validated by significant
changes in the separate parameters of lung function and
airway hyperresponsiveness. Similar findings, from a study
in the Slovak republic (75), of reduced concentrations of
plasma selenium in patients with asthma compared to that
of controls, would also lend support to this line of thought.
Conversely, in severe, brittle asthma (72) dietary intake of
selenium did not relate to asthma severity. As with
magnesium and sodium, there is insucient evidence as
yet to recommend dietary supplementation with selenium in
asthma.
Antioxidant vitamins
It has also been suggested, quite logically, that reduced
intakes of the antioxidant vitamins A, C and E might be
important in the pathogenesis of asthma and there is some
supporting evidence for this. This has been examined in
regard to fruit and vegetable consumption. The relationship
between lung function and the reported frequency of
consumption of winter fresh fruit and fruit juice was
studied (76) among 1502 life-long non-smokers and 1357
current smokers aged 18–69 years. The mean FEV1 among
those who never drank fruit juice and ate fresh fruit less
than once a week in winter, was lower than for other
subjects after adjusting for age, sex, height, smoking, region
of residence and socio-economic group by about 80 ml.
More specifically to asthma, demonstration that in adults
the lowest intakes of vitamin C were associated with a more
than five-fold increased risk of bronchial reactivity, has
provided evidence that antioxidants may have a modula-
tory effect in asthma (77). This would be consistent with the
hypothesis (78) that the observed reduction in antioxidant
intake in the U.K. diet over the last 25 years has been a
factor in the increase in the prevalence of asthma over the
same period. This concept was taken a step further by the
MORGEN study (79), which investigated the relationships
between the antioxidant vitamins C, E and b-carotene and
the presence of respiratory symptoms and level of lung
function. In this large study (6555 adults) a high intake of
vitamin C or b-carotene was associated with higher lung
function but did not appear to protect against respiratory
symptoms (cough, phlegm, productive cough, wheeze and
shortness of breath). It remains to be seen whether the
current healthy eating advice ‘Take 5’ (i.e. 5 portions of
fruit and vegetable daily) will have any impact in this
country in patients with asthma. However, a New Zealand
study (80) has recently shown increasing fruit and vegetable
consumption leads to an increase in plasma concentrations
of vitamin C and a and b-carotene. Further studies are
necessary to examine whether an increase in plasma levelsimpacts on disease state, as for a number of antioxidant
vitamins, plasma levels only poorly correlate with overall
antioxidant status.
Vitamin C
Vitamin C is the major antioxidant substance in the airways
where it may act to protect against both endogenous and
exogenous oxidant molecules (10). Studies conducted into
the possible relationship between vitamin C and lung
function suggest a short-term protective effect of vitamin C
on airway responsiveness (77,81–82) but it has not yet been
shown whether consistent supplementation with vitamin C
would confer a positive effect on objective measures of lung
function or symptoms.
Vitamins A and E
There are considerably fewer studies on vitamin A and E
with respect to respiratory disease and lung function.
Dietary vitamin A levels have been shown to be inversely
associated with airway obstruction in a U.S. study using
national survey data (83), while a further U.S. study found
that a decreased level of serum retinol predicted an
increased risk of airflow obstruction 5 years later (9).
However, it was not clear whether the low serum retinol
levels affected the disease and its rate of progression, or
whether the disease resulted in low serum levels through its
effect on appetite and dietary intake. In a study of a group
of elderly subjects (12), dietary intake of vitamin E was
positively correlated with lung function—for every extra
PRACTICE POINTS
. Consider sub-optimal intake of nutrients when
taking patient history.
. Dietary assessment of patient’s food intake should
be routine in severe asthma.
. Supplementation with nutrients thought to be
important in asthma, has not shown clinical
ecacy.
. Multidisciplinary team of physician, dietitian and
nurse provides the best patient care.
RESEARCH AGENDA
. Studies of supplementation with nutrients thought
to be important is asthma need to be conducted.
. Objective markers of sub-optimal nutrient intake
need to be validated.
. Validity of dietary data should always be
considered when assessing nutrient intake and the
diet/disease relationship.
TABLE 3. Dietary intake of vitamins A and E in patients with brittle asthma
Nurtient RNI Median dietary intake Median dietary intake Median dietary intake
Brittle
asthma
(IQR) Non-
brittle
asthma
(IQR) Healthy
adults
(IQR)
Vit.A 600 mg day71 522?5 (270.0–798.0) 869?5* (667?5–1189?5) 706.5** 580?0–987?5)
Vit.E 3 mg/day (SI)71 3?4 2?0–3?9 4?6 ˆ (3?3–6?3) 4?5^ (3?0–6?4)
brittle asthma : non-brittle asthma, *P=0?01; brittle asthma : non-brittle asthma, ^P=0?005;
brittle asthma : healthy adults, **P=0?04; brittle asthma : healthy adults, ^ ^P=0?007.
IQR: interquartile range; RNI: reference nutrient intake; SI: safe intake.
DIET AND ASTHMA 9311 mg increase in vitamin E in the daily diet, FEV1 increased
by an estimated mean of 54 ml.
In asthma, there has been little work in general asthmatic
populations. A case control study (72) in brittle asthma
demonstrated significantly lower intakes of vitamin A in
brittle asthma compared both to non-brittle asthma and
healthy adults. In the same study, dietary intakes of vitamin
E were also found to be significantly lower than in subjects
with non-brittle asthma and healthy adults (P=0?005 and
0?007 respectively), with significantly more subjects with
brittle asthma whose intakes were sub-optimal compared to
subjects with non-brittle asthma and healthy adults (Table
3). Further evidence is needed before recommendations can
be made for dietary supplementation with vitamin A and E.
Summary
Adverse reactions to food in asthma are now suciently
well documented to be regarded as real and to demonstrate
that recognition can result in significant improvement at an
individual level. There is no clear idea of the true prevalence
of adverse responses to foods in asthmatic populations.
Relying on skin prick tests to determine food allergy is
inaccurate and unwise, and the consequent widespread use
of extreme food avoidance measures in individuals with
modest asthma is not to be advised. Some foods can easily
be recognized as causes of acute severe responses such as
peanuts and shellfish but these, while potentially causing
life-threatening attacks, are unlikely to be the cause of long-
term destabilization of asthma. Conversely, where intoler-
ance of staple foods such as milk/milk products and wheat
is recognized, dietary avoidance is important in stabilizing
asthma. This usually means that a major change in dietary
habits is required, which is often dicult to undertake
consistently. This can be reinforced by the observation that
some patients, known to be allergic to a specific food stuff,
can ‘get away with’ eating the forbidden food if their
asthma is going through a good period, whereas theydaren’t try the food if their asthma is at the time poorly
controlled. Whether such occasional doses of allergen
maintain the adverse immune response in these patients
or whether it is of no import in the long run is not known. It
does, however, identify the need to balance the other needs
of the patient who may have been advised to avoid a food
which is a great favourite and who may feel that an
occasional treat is well worth the potential risk!
Sub-optimal nutrient intake and the resultant reduced
antioxidant activity may enhance asthmatic inflammation
consequently contributing to bronchial hyperreactivity, but
prospective studies of supplementation therapy will be
needed to confirm this. A recent review of nutrition and
asthma (84) concluded, ‘It is clear from a review of the
existing data that there is no proven role for nutritional
therapy in the management of asthma. Until more definitive
studies are completed, the use of nutritional supplements
for the treatment of asthma cannot be recommended.’
There is no published evidence to 1999 to suggest that this
conclusion can be altered.
In both areas, food intolerance and nutrient intake, the
research agendas suggested need to be taken up. In food
intolerance, the development of simple laboratory diag-
nostic tests would perhaps encourage clinicians to investi-
gate the phenomenon in patients where they are currently
put off from doing so by cumbersome dietary manipula-
tions. They may even be more convinced of the phenom-
enon itself if more accurate, objective markers of response
could be found and the mechanisms of the response were
understood. Epidemiological studies would help demon-
strate something of the scale of food intolerance and, as a
consequence, encourage appropriate resources to be made
available for further research and treatment. In the study of
the effects of sub-optimal intake of nutrients thought to be
important in lung health, and, conversely, of their
supplementation, there is much to be pursued. However,
important considerations concerning the validity of dietary
intake data, and the availability of and use of validated
objective biological markders of dietary intake, should be
weighed in order to avoid false conclusions being drawn
932 J. C. BAKER AND J. G. AYRESabout the diet–asthma relationship. Currently, in asthma,
available data are insucient to implicate any dietary
factor as causal (85).
In spite of the limitations of knowledge outlined above, it
is the opinion of the authors that in caring for the patient
with asthma, consideration should be given to adverse
reactions to food and sub-optimal intakes of nutrients when
taking the patient history since one or both factors may be
impacting on day to day management of the disease; and
that a multidisciplinary team approach, of physician,
dietitian and nurse, provides the best patient care.
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